Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
Graziella Pompei, Cardiologist at Romagna Local Health Authority, PHD Student at University of Ferrara, shared on LinkedIn:
”Is aspirin still a valid alternative to clopidogrel in the context of double antithrombotic therapy (antiplatelet plus OAC) in patients requiring chronic OAC undergoing PCI with DES implantation?
Our post-hoc analysis of the PERSEO registry, available online on Journal of Thrombosis and Thrombolysis and presented at the EuroPCR 2026 Congress, aimed to address this question.”
Title: Clopidogrel vs. aspirin in addition to oral anticoagulation as part of double antithrombotic therapy following PCI: a post-hoc analysis of the PERSEO registry
Authors: Andrea Rubboli, Graziella Pompei, Salvatore De Rosa, Paolo Calabrò, Carolina Moretti, Bernardo Cortese, Mauro Colletta, Vanessa Porretta, Giuseppe Andò, Alessandro Sciahbasi
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series